CD44 and breast carcinoma: In the latter, it was also shown that GMI-1271 targets MCF7 breast cancer stem cells (CD44+CD24−) homing to the bone marrow, pointing out a role of E-selectin in bone marrow dissemination of cancer stem cells in breast cancer (102).